244 related articles for article (PubMed ID: 12881423)
1. Myeloid lineage switch of Pax5 mutant but not wild-type B cell progenitors by C/EBPalpha and GATA factors.
Heavey B; Charalambous C; Cobaleda C; Busslinger M
EMBO J; 2003 Aug; 22(15):3887-97. PubMed ID: 12881423
[TBL] [Abstract][Full Text] [Related]
2. Antagonistic effect of CCAAT enhancer-binding protein-alpha and Pax5 in myeloid or lymphoid lineage choice in common lymphoid progenitors.
Hsu CL; King-Fleischman AG; Lai AY; Matsumoto Y; Weissman IL; Kondo M
Proc Natl Acad Sci U S A; 2006 Jan; 103(3):672-7. PubMed ID: 16407117
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5.
Pongubala JM; Northrup DL; Lancki DW; Medina KL; Treiber T; Bertolino E; Thomas M; Grosschedl R; Allman D; Singh H
Nat Immunol; 2008 Feb; 9(2):203-15. PubMed ID: 18176567
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Notch1 function by in vitro T cell differentiation of Pax5 mutant lymphoid progenitors.
Höflinger S; Kesavan K; Fuxa M; Hutter C; Heavey B; Radtke F; Busslinger M
J Immunol; 2004 Sep; 173(6):3935-44. PubMed ID: 15356142
[TBL] [Abstract][Full Text] [Related]
5. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5.
Nutt SL; Heavey B; Rolink AG; Busslinger M
Nature; 1999 Oct; 401(6753):556-62. PubMed ID: 10524622
[TBL] [Abstract][Full Text] [Related]
6. Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway.
Yu D; Allman D; Goldschmidt MH; Atchison ML; Monroe JG; Thomas-Tikhonenko A
Blood; 2003 Mar; 101(5):1950-5. PubMed ID: 12406913
[TBL] [Abstract][Full Text] [Related]
7. Reversion of B cell commitment upon loss of Pax5 expression.
Mikkola I; Heavey B; Horcher M; Busslinger M
Science; 2002 Jul; 297(5578):110-3. PubMed ID: 12098702
[TBL] [Abstract][Full Text] [Related]
8. Biphenotypic B-lymphoid/myeloid cells expressing low levels of Pax5: potential targets of BAL development.
Simmons S; Knoll M; Drewell C; Wolf I; Mollenkopf HJ; Bouquet C; Melchers F
Blood; 2012 Nov; 120(18):3688-98. PubMed ID: 22927250
[TBL] [Abstract][Full Text] [Related]
9. Distribution and expression analysis of transcription factors in tissues and progenitor cell populations of the goldfish (Carassius auratus L.) in response to growth factors and pathogens.
Katzenback BA; Karpman M; Belosevic M
Mol Immunol; 2011 May; 48(9-10):1224-35. PubMed ID: 21474183
[TBL] [Abstract][Full Text] [Related]
10. Identification of Pax5 target genes in early B cell differentiation.
Pridans C; Holmes ML; Polli M; Wettenhall JM; Dakic A; Corcoran LM; Smyth GK; Nutt SL
J Immunol; 2008 Feb; 180(3):1719-28. PubMed ID: 18209069
[TBL] [Abstract][Full Text] [Related]
11. Rapid in vivo analysis of mutant forms of the LAT adaptor using Pax5-Lat double-deficient pro-B cells.
Ardouin L; Rolink AG; Mura AM; Gommeaux J; Melchers F; Busslinger M; Malissen M; Malissen B
Eur J Immunol; 2005 Mar; 35(3):977-86. PubMed ID: 15719364
[TBL] [Abstract][Full Text] [Related]
12. Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells.
Delogu A; Schebesta A; Sun Q; Aschenbrenner K; Perlot T; Busslinger M
Immunity; 2006 Mar; 24(3):269-81. PubMed ID: 16546096
[TBL] [Abstract][Full Text] [Related]
13. Long-term in vivo reconstitution of T-cell development by Pax5-deficient B-cell progenitors.
Rolink AG; Nutt SL; Melchers F; Busslinger M
Nature; 1999 Oct; 401(6753):603-6. PubMed ID: 10524629
[TBL] [Abstract][Full Text] [Related]
14. B-Lymphoma cells with epigenetic silencing of Pax5 trans-differentiate into macrophages, but not other hematopoietic lineages.
Hodawadekar S; Yu D; Cozma D; Freedman B; Sunyer O; Atchison ML; Thomas-Tikhonenko A
Exp Cell Res; 2007 Jan; 313(2):331-40. PubMed ID: 17098231
[TBL] [Abstract][Full Text] [Related]
15. Fidelity and infidelity in commitment to B-lymphocyte lineage development.
Rolink AG; Schaniel C; Busslinger M; Nutt SL; Melchers F
Immunol Rev; 2000 Jun; 175():104-11. PubMed ID: 10933595
[TBL] [Abstract][Full Text] [Related]
16. Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1.
Souabni A; Cobaleda C; Schebesta M; Busslinger M
Immunity; 2002 Dec; 17(6):781-93. PubMed ID: 12479824
[TBL] [Abstract][Full Text] [Related]
17. Pax5 determines B- versus T-cell fate and does not block early myeloid-lineage development.
Cotta CV; Zhang Z; Kim HG; Klug CA
Blood; 2003 Jun; 101(11):4342-6. PubMed ID: 12560221
[TBL] [Abstract][Full Text] [Related]
18. Monoallelic expression of Pax5: a paradigm for the haploinsufficiency of mammalian Pax genes?
Nutt SL; Busslinger M
Biol Chem; 1999 Jun; 380(6):601-11. PubMed ID: 10430025
[TBL] [Abstract][Full Text] [Related]
19. Developmental plasticity of lymphocytes.
Cobaleda C; Busslinger M
Curr Opin Immunol; 2008 Apr; 20(2):139-48. PubMed ID: 18472258
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of myeloid lineage conversion using mice expressing an inducible form of C/EBP alpha.
Fukuchi Y; Shibata F; Ito M; Goto-Koshino Y; Sotomaru Y; Ito M; Kitamura T; Nakajima H
EMBO J; 2006 Jul; 25(14):3398-410. PubMed ID: 16858416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
